首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4442631篇
  免费   367366篇
  国内免费   15744篇
耳鼻咽喉   63107篇
儿科学   137839篇
妇产科学   115783篇
基础医学   679044篇
口腔科学   123436篇
临床医学   402337篇
内科学   812387篇
皮肤病学   107313篇
神经病学   382000篇
特种医学   174763篇
外国民族医学   981篇
外科学   672671篇
综合类   127094篇
现状与发展   23篇
一般理论   2637篇
预防医学   379612篇
眼科学   103745篇
药学   314278篇
  24篇
中国医学   11970篇
肿瘤学   214697篇
  2021年   58655篇
  2020年   37067篇
  2019年   61442篇
  2018年   77910篇
  2017年   59035篇
  2016年   65371篇
  2015年   78794篇
  2014年   114000篇
  2013年   181096篇
  2012年   131137篇
  2011年   135111篇
  2010年   128592篇
  2009年   130320篇
  2008年   120071篇
  2007年   127520篇
  2006年   135824篇
  2005年   130414篇
  2004年   130488篇
  2003年   120565篇
  2002年   110603篇
  2001年   157071篇
  2000年   153282篇
  1999年   142041篇
  1998年   71772篇
  1997年   68105篇
  1996年   65956篇
  1995年   61776篇
  1994年   55844篇
  1993年   51832篇
  1992年   105053篇
  1991年   100280篇
  1990年   95380篇
  1989年   92880篇
  1988年   86494篇
  1987年   84906篇
  1986年   80533篇
  1985年   78866篇
  1984年   66633篇
  1983年   59451篇
  1982年   48430篇
  1981年   45133篇
  1980年   42438篇
  1979年   58525篇
  1978年   47470篇
  1977年   42012篇
  1976年   39015篇
  1975年   38293篇
  1974年   42982篇
  1973年   41117篇
  1972年   38601篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
982.
983.
984.
985.
986.

Background

Clear cell renal cell carcinoma (ccRCC) is known to occur across the adult lifetime traversing the spectrum of age-related organismal changes. Little is known as to how the aging process may affect the course of renal cell carcinoma (RCC) and the repertoire of genes involved.

Methods

Using The Cancer Genome Atlas (n?=?436) and Cancer Genomics of the Kidney (n?=?89) datasets, we applied regression analysis to examine associations between patient age and gene expression profiles in ccRCC tumors and normal kidney tissues. Pathway enrichment analysis was performed to identify cellular process that is affected by aging in ccRCC. Moreover, connectivity mapping analysis was used to predict age-dependent response to drug treatments.

Results

Our analysis revealed different age-dependent gene expression spectra in ccRCC and normal kidney tissues. These findings were significant and independently reproducible in both datasets examined. Age up-regulated genes, showing higher expression in older patients, were significantly enriched (false discovery rate <0.05) in normal tissues for pathways associated with immune response and extracellular matrix organization, whereas age up-regulated genes in tumors were enriched for metabolism and oxidation pathways. Strikingly, age down-regulated genes in normal cells were also enriched for metabolism and oxidation, while those in tumors were enriched for extracellular matrix organization. Further in silico analysis of potential drug targets predicted preferential efficacy of Phosphoinositide 3-kinase inhibitor or immunotherapy in association with age.

Conclusion

We report on previously unrecognized associations between age and molecular underpinnings of RCC, including age-associated expression of genes implicated in RCC development or treatment.  相似文献   
987.
988.
Introduction: Tamoxifen dominates the anti-estrogenic therapy in the early and metastatic breast cancer setting. Tamoxifen has a complex metabolism, being mainly metabolized by CYP2D6 into its 30–100 times more potent metabolite, endoxifen. Recently, a phase I study in which endoxifen as an orally z-endoxifen hydrochloride has been successfully evaluated.

Areas covered: the principal pharmacogenetic and non-genetic differences in the pharmacology of tamoxifen and endoxifen are evaluated. To this end, references from PubMed, Embase or Web of Science, among others, were reviewed As non-genetic factors, important differences and similarities such age, or adherence to tamoxifen therapy are comprehensively illustrated. Additionally, since CYP2D6 genotypes are considered the main limitation of tamoxifen, many studies have investigated the association between the worsened clinical outcomes in patients with non-functional CYP2D6 genotypes. In this review, an overview of the research on this field is presented. Also, a summary describing the literature about individualizing tamoxifen therapy with endoxifen concentrations and its limitations is listed.

Expert opinion: z-endoxifen hydrochloride is only investigated in the metastatic setting, still more research is required before its place in therapeutics is known. Similarly, monitoring tamoxifen efficacy based on endoxifen concentrations might not be overall recommended due to the limited evidence available.  相似文献   

989.
990.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号